BioNTech SE - ADR

XNAS: BNTX

Weak Stock

Download real time

89.55 -2.44 (-2.65%)

27.78% Fall from 52W High

1.2M

XNAS Volume

XNAS 15 May, 2026 5:30 PM (EDT)

Insider Trading disclosures for BioNTech SE (ADR)

The latest disclosure was made by Ramon Gomez Zapata in BioNTech SE (ADR) where a trade of 18,879 Option (right to buy) done was reported to US exchanges on May 12, 2026.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Ramon Gomez Zapata	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 May 2026	18,879	18,879	-		-	Option (right to buy)
Ramon Gomez Zapata	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 May 2026	15,103	15,103	-		-	Performance Share Unit
Kylie Jimenez	Chief People Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 May 2026	10,488	10,488	-		-	Option (right to buy)
Kylie Jimenez	Chief People Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 May 2026	8,391	8,391	-		-	Performance Share Unit

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

Screeners based on Insider Trading and SAST parameters